Applicability of pan-TRK immunohistochemistry for identification of NTRK fusions in lung carcinoma

Abstract In the last two decades, various therapies have been introduced for lung carcinoma patients, including tyrosine-kinase inhibitors for different mutations. While some of them are specific to specific tumor types, others, like NTRK1–3 fusions, are found in various solid tumors. The occurrence...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Simon Strohmeier, Iva Brcic, Helmut Popper, Bernadette Liegl-Atzwanger, Jörg Lindenmann, Luka Brcic
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/a1931cd4b02e42c9bec476b343ff09ed
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares